Peer Review reports
From: KRAS is a molecular determinant of platinum responsiveness in glioblastoma
| Original Submission | ||
|---|---|---|
| 26 Aug 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 10 Oct 2023 | Reviewed | Reviewer Report |
| 23 Oct 2023 | Reviewed | Reviewer Report |
| 16 Nov 2023 | Author responded | Author comments - Samantha Messina |
| Resubmission - Version 3 | ||
| 16 Nov 2023 | Submitted | Manuscript version 3 |
| 18 Nov 2023 | Author responded | Author comments - Samantha Messina |
| Resubmission - Version 4 | ||
| 18 Nov 2023 | Submitted | Manuscript version 4 |
| 24 Nov 2023 | Author responded | Author comments - Samantha Messina |
| Resubmission - Version 5 | ||
| 24 Nov 2023 | Submitted | Manuscript version 5 |
| 11 Dec 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 13 Dec 2023 | Editorially accepted | |
| 15 Jan 2024 | Article published | 10.1186/s12885-023-11758-6 |
You can find further information about peer review here.